DSIJ Mindshare

Stocks below Rs 100: Only buyers seen in these scrips on July 14

As June inflation data came in hotter than anticipated, hitting its highest level since 1981 along with fuelling concerns that Federal Reserve may need to raise interest rates more forcefully in the coming months to slow price rises, the stocks in the US markets declined on Wednesday. 

Sayali Kotwal 0 1228 Article rating: 4.0

At 12.30 pm on Thursday, the headline equity indices, i.e. Sensex and Nifty 50 were trading flat, as Mainland China markets rose in Asia-Pacific on Thursday after Australia’s unemployment rate fell and Singapore tightened its monetary policy.  

Shilpa Biologicals join hands with Mylab to enter in vaccine and personalised therapeutics business

Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Ltd, has announced a strategic tie-up with Mylab Discovery Solutions, India’s leading diagnostic solutions provider.

Sayali Kotwal 0 738 Article rating: 5.0

Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Ltd, has announced a strategic tie-up with Mylab Discovery Solutions, India’s leading diagnostic solutions provider. With this association, Shilpa Medicare expects to venture into the vaccine and therapeutics segment

SMS Pharmaceuticals jumps 4.31 per cent; heres why!

SMS Pharma has received a non-exclusive license through the Medicines Patent Pool (MPP) to manufacture molnupiravir. Molnupiravir is the first oral antiviral medicine available for COVID-19 therapy.

Armaan Madhani 2 634 Article rating: 4.5

SMS Pharma is a global player in API and intermediates manufacturing having a strong research and manufacturing team supported by state-of-the-art facilities.

T20 breakout stocks: Best swing trading stocks to keep an eye on!

Karan Dsij 0 2155 Article rating: 3.3

What a day of trading it was on D-Street today! The initial hour of today’s trading session was quite volatile as Nifty swung both ways and at one point in time, it had slipped below the 17,600 mark. However, the bulls continued their New Year Celebration and logged a marvellous rally of over 1 per cent on Tuesday.   

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR